Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy

被引：0
|
作者：
De Oliveira, Antonia [1 ]
Lei, Joyce [1 ]
Liu, Jiayuan [1 ]
Roche, Morgan [1 ]
Lin, Jerry [1 ]
Alfonso, Roberto [2 ]
Sadiq, Saud [1 ]
机构：
[1] Tisch Multiple Sclerosis Res Ctr New York, New York, NY USA
[2] Tisch Multiple Sclerosis, New York, NY USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202245
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S21.001
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection
    Lopez, Carlos A.
    Chitty, David
    Chi, Jeffrey
    Saif, Wasif
    Goldberg, Bradley
    BLOOD, 2020, 136
  • [22] Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
    Januel, Edouard
    Hajage, David
    Labauge, Pierre
    Maillart, Elisabeth
    De Seze, Jerome
    Zephir, Helene
    Pelletier, Jean
    Guilloton, Laurent
    Bensa, Caroline
    Heinzlef, Olivier
    Casez, Olivier
    Biotti, Damien
    Bourre, Bertrand
    Vukusic, Sandra
    Maurousset, Aude
    Berger, Eric
    Laplaud, David
    Lebrun-Frenay, Christine
    Dubessy, Anne-Laure
    Branger, Pierre
    Thouvenot, Eric
    Clavelou, Pierre
    Sellal, Francois
    Manchon, Eric
    Moreau, Thibault
    Papeix, Caroline
    Tubach, Florence
    Louapre, Celine
    JAMA NETWORK OPEN, 2023, 6 (06) : E2319766
  • [23] Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
    Heming, Michael
    Wiendl, Heinz
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (06)
  • [24] Humoral vaccine response and COVID-19 hospitalizations in vaccinated multiple sclerosis patients treated with rituximab
    Torgauten, H.
    Onyangp, T.
    Hallin, E.
    Serkland, T.
    Skrede, S.
    Cox, R.
    Langeland, N.
    Myhr, K.
    Torkildsen, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 736 - 736
  • [25] COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
    Ito, Yusuke
    Honda, Akira
    Kurokawa, Mineo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08): : E691 - E707
  • [26] Risk factors for developing lymphopenia and hypogammaglobulinemia in anti-cd20 treated patients with multiple sclerosis
    Vollmer, B.
    Vollmer, T.
    Corboy, J.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 304 - 304
  • [27] Influence of Body Mass Index on B Lymphocyte Repopulation in Multiple Sclerosis Patients Treated with Anti-CD20 Therapy
    Loeffler, Jacob
    Han, May
    NEUROLOGY, 2023, 100 (17)
  • [28] COVID-19 Vaccine Response in People with Multiple Sclerosis
    Tallantyre, Emma C.
    Vickaryous, Nicola
    Anderson, Valerie
    Asardag, Aliye Nazli
    Baker, David
    Bestwick, Jonathan
    Bramhall, Kath
    Chance, Randy
    Evangelou, Nikos
    George, Katila
    Giovannoni, Gavin
    Godkin, Andrew
    Grant, Leanne
    Harding, Katharine E.
    Hibbert, Aimee
    Ingram, Gillian
    Jones, Meleri
    Kang, Angray S.
    Loveless, Samantha
    Moat, Stuart J.
    Robertson, Neil P.
    Schmierer, Klaus
    Scurr, Martin J.
    Shah, Sita Navin
    Simmons, Jessica
    Upcott, Matthew
    Willis, Mark
    Jolles, Stephen
    Dobson, Ruth
    ANNALS OF NEUROLOGY, 2022, 91 (01) : 89 - 100
  • [29] Characteristics of Patients Switching from Anti-CD20 Therapy to Natalizumab in the Treatment of Multiple Sclerosis
    Vollmer, Brandi
    Nair, Kavita
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    NEUROLOGY, 2019, 92 (15)
  • [30] Characterization of cytokine profiles in patients with multiple sclerosis under anti-CD20 therapy with ocrelizumab
    Koerner, Gudrun
    Gingele, Stefan
    Christina, Anna
    Pietschmann, Saparilla
    Konen, Franz Felix
    Jendretzky, Konstantin Fritz
    Schwenkenbecher, Philipp
    Hummert, Martin W.
    Jacobs, Roland
    Skripuletz, Thomas
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 231 - 232
12345